Funding · Company

Rezo Therapeutics, Inc.

San Francisco, CABiotech & Pharma

Rezo Therapeutics, Inc. of San Francisco, CA has disclosed $68M across 1 Form D offering filed with the SEC on Aug 18, 2025.

$68M

Total disclosed

Form D offering

2021

Incorporated

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$68M

Form D · Aug 18, 2025 ↗

Q3 2025 · 2 amendments, first filed Dec 1, 2022 · target $80M

Filing details

HeadquartersSan Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001956559Offerings on file1

Links

All SEC filings for this company ↗ rezotherapeutics.com ↗ Startups in San Francisco → More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →